These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 9293077)
1. Measles antibody prevalence after mass immunization campaign in Niterói, state of Rio de Janeiro, Brazil. Oliveira SA; Siqueira MM; Mann GF; Costa AJ; Almeida MT; Stavola MS; Tomasini H; Nascimento JP Rev Inst Med Trop Sao Paulo; 1996; 38(5):355-8. PubMed ID: 9293077 [TBL] [Abstract][Full Text] [Related]
2. Measles antibody prevalence after mass immunization in São Paulo, Brazil. Pannuti CS; Moraes JC; Souza VA; Camargo MC; Hidalgo NT Bull World Health Organ; 1991; 69(5):557-60. PubMed ID: 1959156 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of measles antibody among children under 15 years of age in Santa Cruz, Bolivia: implications for vaccination strategies. Cutts FT; Bartoloni A; Guglielmetti P; Gil F; Brown D; Bianchi Bandinelli ML; Roselli M Trans R Soc Trop Med Hyg; 1995; 89(1):119-22. PubMed ID: 7747295 [TBL] [Abstract][Full Text] [Related]
4. Seroepidemiological study on prevalence of measles antibodies in Urawa City. Tsuji A; Tanioku Y; Nakayama T Keio J Med; 1998 Dec; 47(4):209-11. PubMed ID: 9884515 [TBL] [Abstract][Full Text] [Related]
5. Serological findings during a measles outbreak occurring in a population with high vaccine coverage. Oliveira SA; Siqueira MM; Costa AJ; Almeida MT; Nascimento JP Rev Inst Med Trop Sao Paulo; 1995; 37(5):421-5. PubMed ID: 8729752 [TBL] [Abstract][Full Text] [Related]
6. [Investigation of antibodies against measles antigen in institutionalized patients with severe motor and intellectual disability]. Machida Y; Yamamoto J; Yano Y; Yano T Kansenshogaku Zasshi; 2008 Jul; 82(4):328-34. PubMed ID: 18697485 [TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of neutralizing antibodies to measles virus in a vaccinated population in Iran, 1998. Loo MK; Sabahi F; Soleimanjdahi H; Kazemnejad A; Roustai MH Eur J Epidemiol; 2003; 18(11):1085-9. PubMed ID: 14620944 [TBL] [Abstract][Full Text] [Related]
8. Immunity to measles in the Croatian population. Borcić B; Mazuran R; Kaić B Eur J Epidemiol; 2003; 18(11):1079-83. PubMed ID: 14620943 [TBL] [Abstract][Full Text] [Related]
9. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody. Ratnam S; Gadag V; West R; Burris J; Oates E; Stead F; Bouilianne N J Clin Microbiol; 1995 Apr; 33(4):811-5. PubMed ID: 7790442 [TBL] [Abstract][Full Text] [Related]
10. [Study on the immunization effect of measles vaccine by capture-EIA]. Fang H Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):297-9. PubMed ID: 1300252 [TBL] [Abstract][Full Text] [Related]
11. The sero-epidemiology of measles in children from Eastern Turkey. Altinkaynak S; Ertekin V; Güraksin A; Kiliç A; Yiğit N West Indian Med J; 2005 Sep; 54(4):236-7. PubMed ID: 16312189 [No Abstract] [Full Text] [Related]
12. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan. Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran. Karimi A; Arjomandi A; Alborzi A; Rasouli M; Kadivar MR; Obood B; Pourabbas B East Mediterr Health J; 2004; 10(4-5):468-73. PubMed ID: 16335636 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia). Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946 [TBL] [Abstract][Full Text] [Related]
15. Measles, killer of millions in developing countries: strategy for rapid elimination and continuing control. Sabin AB Eur J Epidemiol; 1991 Jan; 7(1):1-22. PubMed ID: 1902797 [TBL] [Abstract][Full Text] [Related]
16. Measles epidemiology and its implications for a vaccination programme in Oman. Patel PK; Al-Awaidy ST; Bawikar S; Al-Busaidy S; Al-Mahrooqi S East Mediterr Health J; 2008; 14(3):579-89. PubMed ID: 18720622 [TBL] [Abstract][Full Text] [Related]
17. Comparison of indirect immunofluorescence test for measles antibodies with haemagglutination inhibition and plaque neutralization tests. de Souza VA; Pannuti CS; de Godoy CV; Albrecht P; Lopes MH; Mendonça Jda S Rev Inst Med Trop Sao Paulo; 1990; 32(5):360-3. PubMed ID: 2135477 [TBL] [Abstract][Full Text] [Related]
18. Sustained measles elimination in Australia and priorities for long term maintenance. Gidding HF; Wood J; MacIntyre CR; Kelly H; Lambert SB; Gilbert GL; McIntyre PB Vaccine; 2007 May; 25(18):3574-80. PubMed ID: 17300858 [TBL] [Abstract][Full Text] [Related]
19. [Serological evidence of persistent elimination of measles in Czechoslovakia]. Strauss J; Svandová E; Smelhausová M; Mrázová M Cas Lek Cesk; 1989 Mar; 128(13):399-403. PubMed ID: 2790867 [TBL] [Abstract][Full Text] [Related]
20. Comparative Estimates of Crude and Effective Coverage of Measles Immunization in Low-Resource Settings: Findings from Salud Mesoamérica 2015. Colson KE; Zúñiga-Brenes P; Ríos-Zertuche D; Conde-Glez CJ; Gagnier MC; Palmisano E; Ranganathan D; Usmanova G; Salvatierra B; Nazar A; Tristao I; Sanchez Monin E; Anderson BW; Haakenstad A; Murphy T; Lim S; Hernandez B; Lozano R; Iriarte E; Mokdad AH PLoS One; 2015; 10(7):e0130697. PubMed ID: 26136239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]